During Danaher’s company presentation at this year's J.P. Morgan Healthcare conference in San Francisco, the company ...

Zimmer Biomet CEO Ivan Tornos has outlined plans for the largest direct to consumer (DTC) campaign in the company’s history ...

Henry Schein currently has a broad portfolio with over $3bn in corporate and owned brand products and services.

Edwards cited broader TAVR treatment populations and ongoing evidence generation as key growth drivers for the new year.

GE HealthCare CEO Peter Arduini has highlighted the company’s disciplined approach to M&A in order to “fill gaps and add tuck ...

At its J.P. Morgan Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and expressed that ...

Clinical expectations in minimally invasive interventions is rising, making collaboration in the medical value chain ...

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.